CHEE CONLEY (Chief Commercial Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/2/2023ACC: 0001209191-23-054167
Officer· Chief Commercial Officer
Since Sep 2021
-6K
Net shares
Net seller
$13.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
17K acquired · 23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17K
Price / share
—
Trade value
—
% of position
1266.8%
10/31/2023
1.34K→18.34K
Common Stock
Direct
Shares
−6K
Price / share
$2.22
Trade value
$13.33K
% of position
32.7%
11/1/2023
18.34K→12.34K
Total
Net shares
+11K
Net value
-$13.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2023 | M · Option Exercise | +17K | — | — | 1266.8% | 1.34K | 18.34K |
| Common Stock Direct | 11/1/2023 | F · Tax Withholding | −6K | $2.22 | $13.33K | 32.7% | 18.34K | 12.34K |
| Total | +11K | -$13.33K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
17K shares
Shares
−17K
Strike price
Held after
17K
Exercisable
—
10/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17K shares | 10/31/2023 | M · Option Exercise | −17K | — | 17K |